Histologic healing and factors associated with complete remission following conventional treatment in ulcerative colitis

Background: Endoscopic and histological activity scores in ulcerative colitis (UC) are associated with clinical outcomes and have become important targets of clinical trials. However, these endpoints have been scarcely investigated in patients receiving only conventional treatment. Objective: We aim...

Full description

Bibliographic Details
Main Authors: Øyvind Steinsbø, Arne Carlsen, Ole Gunnar Aasprong, Lars Aabakken, Espen Tvedt-Gundersen, Steinar Bjørkhaug, Rune Gjerde, Lars Normann Karlsen, Tore Grimstad
Format: Article
Language:English
Published: SAGE Publishing 2022-12-01
Series:Therapeutic Advances in Gastroenterology
Online Access:https://doi.org/10.1177/17562848221140659
_version_ 1811311642239041536
author Øyvind Steinsbø
Arne Carlsen
Ole Gunnar Aasprong
Lars Aabakken
Espen Tvedt-Gundersen
Steinar Bjørkhaug
Rune Gjerde
Lars Normann Karlsen
Tore Grimstad
author_facet Øyvind Steinsbø
Arne Carlsen
Ole Gunnar Aasprong
Lars Aabakken
Espen Tvedt-Gundersen
Steinar Bjørkhaug
Rune Gjerde
Lars Normann Karlsen
Tore Grimstad
author_sort Øyvind Steinsbø
collection DOAJ
description Background: Endoscopic and histological activity scores in ulcerative colitis (UC) are associated with clinical outcomes and have become important targets of clinical trials. However, these endpoints have been scarcely investigated in patients receiving only conventional treatment. Objective: We aimed to assess the deep and complete remission rates after 3 months of conventional treatment in patients with newly diagnosed UC with moderate to severe endoscopic activity. We also aimed to investigate whether selected clinical and biochemical variables at baseline were associated with complete remission status after 3 months. Design: This was a prospective cohort study. Methods: Newly diagnosed patients with active UC commencing 5-aminosalicylate, corticosteroid, and/or azathioprine treatment were consecutively included. Clinical, biochemical, endoscopic, and histological data were collected at baseline and after 3 months. Rates of clinical remission (Partial Mayo Score ⩽ 2), mucosal healing (Mayo Endoscopic Score ⩽ 1), and histologic healing (Nancy Index ⩽ 1) were determined. Deep remission was assessed as clinical remission plus mucosal healing and complete remission as deep remission plus histologic healing. Predictors of complete remission were identified by logistic regression. Results: A total of 180 patients were included in the study. Deep remission and complete remission occurred in 62.8% and 42.2% of patients, respectively. Thus, of patients in deep remission one-third had persistent histologic activity. Histologic activity in mucosally healed patients was associated with higher symptom scores and faecal calprotectin levels. Of baseline variables, less endoscopic distribution and disease activity showed strongest association with achieving complete remission, and limited distribution in combination with moderate activity gave highest odds for complete remission (odds ratio: 4.1, 95% confidence interval: 7.69–2.18). Conclusion: In patients with mucosal healing, persistent histologic activity was a common finding and was associated with increased disease activity. Pancolitis and severe inflammatory activity at baseline were associated with lower complete remission rates.
first_indexed 2024-04-13T10:22:26Z
format Article
id doaj.art-faa0db8c67e1476d862b657803474e89
institution Directory Open Access Journal
issn 1756-2848
language English
last_indexed 2024-04-13T10:22:26Z
publishDate 2022-12-01
publisher SAGE Publishing
record_format Article
series Therapeutic Advances in Gastroenterology
spelling doaj.art-faa0db8c67e1476d862b657803474e892022-12-22T02:50:28ZengSAGE PublishingTherapeutic Advances in Gastroenterology1756-28482022-12-011510.1177/17562848221140659Histologic healing and factors associated with complete remission following conventional treatment in ulcerative colitisØyvind SteinsbøArne CarlsenOle Gunnar AasprongLars AabakkenEspen Tvedt-GundersenSteinar BjørkhaugRune GjerdeLars Normann KarlsenTore GrimstadBackground: Endoscopic and histological activity scores in ulcerative colitis (UC) are associated with clinical outcomes and have become important targets of clinical trials. However, these endpoints have been scarcely investigated in patients receiving only conventional treatment. Objective: We aimed to assess the deep and complete remission rates after 3 months of conventional treatment in patients with newly diagnosed UC with moderate to severe endoscopic activity. We also aimed to investigate whether selected clinical and biochemical variables at baseline were associated with complete remission status after 3 months. Design: This was a prospective cohort study. Methods: Newly diagnosed patients with active UC commencing 5-aminosalicylate, corticosteroid, and/or azathioprine treatment were consecutively included. Clinical, biochemical, endoscopic, and histological data were collected at baseline and after 3 months. Rates of clinical remission (Partial Mayo Score ⩽ 2), mucosal healing (Mayo Endoscopic Score ⩽ 1), and histologic healing (Nancy Index ⩽ 1) were determined. Deep remission was assessed as clinical remission plus mucosal healing and complete remission as deep remission plus histologic healing. Predictors of complete remission were identified by logistic regression. Results: A total of 180 patients were included in the study. Deep remission and complete remission occurred in 62.8% and 42.2% of patients, respectively. Thus, of patients in deep remission one-third had persistent histologic activity. Histologic activity in mucosally healed patients was associated with higher symptom scores and faecal calprotectin levels. Of baseline variables, less endoscopic distribution and disease activity showed strongest association with achieving complete remission, and limited distribution in combination with moderate activity gave highest odds for complete remission (odds ratio: 4.1, 95% confidence interval: 7.69–2.18). Conclusion: In patients with mucosal healing, persistent histologic activity was a common finding and was associated with increased disease activity. Pancolitis and severe inflammatory activity at baseline were associated with lower complete remission rates.https://doi.org/10.1177/17562848221140659
spellingShingle Øyvind Steinsbø
Arne Carlsen
Ole Gunnar Aasprong
Lars Aabakken
Espen Tvedt-Gundersen
Steinar Bjørkhaug
Rune Gjerde
Lars Normann Karlsen
Tore Grimstad
Histologic healing and factors associated with complete remission following conventional treatment in ulcerative colitis
Therapeutic Advances in Gastroenterology
title Histologic healing and factors associated with complete remission following conventional treatment in ulcerative colitis
title_full Histologic healing and factors associated with complete remission following conventional treatment in ulcerative colitis
title_fullStr Histologic healing and factors associated with complete remission following conventional treatment in ulcerative colitis
title_full_unstemmed Histologic healing and factors associated with complete remission following conventional treatment in ulcerative colitis
title_short Histologic healing and factors associated with complete remission following conventional treatment in ulcerative colitis
title_sort histologic healing and factors associated with complete remission following conventional treatment in ulcerative colitis
url https://doi.org/10.1177/17562848221140659
work_keys_str_mv AT øyvindsteinsbø histologichealingandfactorsassociatedwithcompleteremissionfollowingconventionaltreatmentinulcerativecolitis
AT arnecarlsen histologichealingandfactorsassociatedwithcompleteremissionfollowingconventionaltreatmentinulcerativecolitis
AT olegunnaraasprong histologichealingandfactorsassociatedwithcompleteremissionfollowingconventionaltreatmentinulcerativecolitis
AT larsaabakken histologichealingandfactorsassociatedwithcompleteremissionfollowingconventionaltreatmentinulcerativecolitis
AT espentvedtgundersen histologichealingandfactorsassociatedwithcompleteremissionfollowingconventionaltreatmentinulcerativecolitis
AT steinarbjørkhaug histologichealingandfactorsassociatedwithcompleteremissionfollowingconventionaltreatmentinulcerativecolitis
AT runegjerde histologichealingandfactorsassociatedwithcompleteremissionfollowingconventionaltreatmentinulcerativecolitis
AT larsnormannkarlsen histologichealingandfactorsassociatedwithcompleteremissionfollowingconventionaltreatmentinulcerativecolitis
AT toregrimstad histologichealingandfactorsassociatedwithcompleteremissionfollowingconventionaltreatmentinulcerativecolitis